China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactur...
HBM Holdings enters strategic biologics R&D collaboration with Sinopharm
Sinopharm Seeks Shareholder Mandate for Up to 10% H-Share Buyback
Sinopharm subsidiary posts steady Q1 profit growth but cash flow weakens
Sinopharm Sets April Board Meeting to Approve First-Quarter 2026 Results
Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities
Shineway Profit Rises Despite Revenue Slump as TCM Sector Resets